Actualités et Activités de PureTech

PureTech fait partie des...

• FTSE SmallCaps.

PureTech est une société cotée sous le symbole boursier PRTC (US).

Voir l'organigramme avec ses 49 principaux dirigeants

Biographies les plus recherchées chez PureTech

• Robert Lyne, Chief Executive Officer
• Kiran Mazumdar-Shaw, Director
• Sharon Barber-Lui, Interim Chairman of the Board

Changements de dirigeants chez PureTech

• Robert Lyne qui était Interim Chief Executive Officer, est promu Chief Executive Officer  (publié le 18 décembre 2025).

Créer une alerte
pour suivre les mouvements de dirigeants chez PureTech.

PureTech a 2 428 concurrents dont Lonza (Suisse), Vertex Pharmaceuticals (Etats—Unis) et Eurofins (Luxembourg).

Actualités en fusion/acquisition en Biotechnologie.

• Eli Lilly has announced the acquisition of AtaiBeckley  (publié le 17 juillet 2026).
• GSK a acquis Nuvalent (publié le 17 juillet 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publié le 15 juillet 2026).

Contacts en Biotechnologie

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer chez Inceptive
• Jan Van de Winkel - President and Chief Executive Officer chez Genmab
• Robert Gould - Board Member chez Fulcrum Therapeutics

En savoir plus sur le secteur Biotechnologie

Derniers communiqués de presse par PureTech

• Notice of Half-Yearly Results | PureTech Health
• PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan | PureTech Health
• PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate | PureTech Health
• PureTech Founded Entity Akili Announces Public Company Board of Director Nominees | PureTech Health
• PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb) | PureTech Health
• PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia | PureTech Health
• PureTech News | PureTech Health
• PureTech Founded Entity Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million | PureTech Health
• Results of Annual General Meeting | PureTech Health
• PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory Complications | PureTech Health
• Voir plus de communiqués de presse Close

Réseaux sociaux à propos de PureTech

• PureTech sur Wikipédia, Google News & Yahoo Finance en 1-click
• PureTech sur LinkedIn, X (Twitter) & YouTube en 1-click